{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:35Z","timestamp":1787022035036,"version":"build-2736575974"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for the National Institutes of Health (US)","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}]},{"DOI":"10.13039\/100010877","name":"Viiv healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206755","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T13:40:10Z","timestamp":1541425210000},"page":"e0206755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-9501","authenticated-orcid":true,"given":"Parastu","family":"Kasaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunaina","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Hernandez Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maunank","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"ref1","unstructured":"HIV\/AIDS JUNPo. Global AIDS update 2016 2016 [03\/16\/2018]. Available from: http:\/\/www.unaids.org\/sites\/default\/Files\/media_asset\/global-AIDS-update-2016_en.pdf<\/ext-link>."},{"key":"ref2","unstructured":"Roser M. HIV \/ AIDS 2017 [updated 02\/08\/201803\/16\/2018]. Available from: https:\/\/ourworldindata.org\/hiv-aids<\/ext-link>."},{"key":"ref3","unstructured":"WHO. Scaling up antiretroviral therapy in resource-limited settings. 2002 2002 [03\/16\/2018]. Available from: http:\/\/www.who.int\/hiv\/pub\/prev_care\/en\/ScalingUp_E.pdf<\/ext-link>."},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"e0125018","DOI":"10.1371\/journal.pone.0125018","article-title":"Projected lifetime healthcare costs associated with HIV infection","volume":"10","author":"F Nakagawa","year":"2015","journal-title":"PloS one"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"ISS Group","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa","volume":"373","author":"TAS Group","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral Therapy for the Prevention of HIV-1 Transmission","volume":"375","author":"MS Cohen","year":"2016","journal-title":"The New England journal of medicine"},{"key":"ref8","unstructured":"European AIDS Clinical Society. European Guidelines for treatment of HIV-positive adults in Europe 2017 [03\/16\/2018]. Available from: http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html<\/ext-link>."},{"key":"ref9","unstructured":"Panel de expertos de GeSIDA y Plan Nacional sobre el Sida. Documento de consenso de GeSIDA\/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualizaci\u00f3n enero 2017) 2017 [03\/16\/2018]. Available from: http:\/\/gesida-seimc.org\/category\/guias-clinicas\/antirretroviral-vigentes\/<\/ext-link>."},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/S2352-3018(16)00007-2","article-title":"Effect of the US National HIV\/AIDS Strategy targets for improved HIV care engagement: a modelling study","volume":"3","author":"M Shah","year":"2016","journal-title":"Lancet HIV"},{"key":"ref11","article-title":"The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States","author":"M Shah","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref12","unstructured":"UNAIDS. AIDSinfo 2016 [03\/16\/2018]. Available from: http:\/\/aidsinfo.unaids.org\/<\/ext-link>."},{"key":"ref13","unstructured":"European Centre for Disease Prevention and Control. HIV\/AIDS Surveillance in Europe 2015 2016 [03\/16\/2018]. Available from: https:\/\/ecdc.europa.eu\/en\/publications-data\/hivaids-surveillance-europe-2015<\/ext-link>."},{"key":"ref14","unstructured":"National Center for Epidemiology. Area of HIV surveillance and risk behaviors.Epidemiological situation of HIV infection in men who have sex with men. 2011."},{"key":"ref15","unstructured":"National Center for Epidemiology \/ General Subdirectorate for Health Promotion and Epidemiology\u2014National Plan on AIDS. Area of HIV surveillance and risk behaviors. Mortality by HIV and AIDS in Spain, year 2014. Evolution 1981\u20132014. 2016."},{"key":"ref16","unstructured":"National Center for Epidemiology \/ General Subdirectorate for Health Promotion and Epidemiology\u2014National Plan on AIDS. Area of HIV surveillance and risk behaviors.Epidemiological Surveillance of HIV and AIDS in Spain: Information System on New HIV Diagnoses and National Registry of AIDS Cases. 2016."},{"issue":"Suppl 1","key":"ref17","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1136\/sti.2008.029991","article-title":"Bayesian melding for estimating uncertainty in national HIV prevalence estimates","volume":"84","author":"L Alkema","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1214\/07-AOAS111","article-title":"Probabilistic Projections of Hiv Prevalence Using Bayesian Melding","volume":"1","author":"L Alkema","year":"2007","journal-title":"Ann Appl Stat"},{"issue":"Suppl 2","key":"ref19","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1136\/sti.2010.044784","article-title":"Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009","volume":"86","author":"T Brown","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13561-014-0015-5","article-title":"Economic impact of HIV\/AIDS: a systematic review in five European countries","volume":"4","author":"M Trapero-Bertran","year":"2014","journal-title":"Health Econ Rev"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eimc.2016.06.013","article-title":"Costs and cost-efficacy analysis of the 2016 GESIDA\/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults","volume":"35","author":"A Rivero","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref22","article-title":"Costs and cost-efficacy analysis of the 2017 GESIDA\/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults","author":"A Rivero","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref23","article-title":"Effectiveness and Cost-effectiveness of HIV Screening Strategies Across Europe","author":"G Mabileau","year":"2017"},{"issue":"26","key":"ref24","doi-asserted-by":"crossref","first-page":"e3961","DOI":"10.1097\/MD.0000000000003961","article-title":"Analysis of contemporary HIV\/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines","volume":"95","author":"M Treskova","year":"2016","journal-title":"Medicine"},{"issue":"18","key":"ref25","first-page":"1746","article-title":"Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy","volume":"173","author":"EP Hyle","year":"2013","journal-title":"JAMA Intern Med"},{"key":"ref26","unstructured":"Services CfMM. Clinical Laboratory Fee Schedule 2017 [02\/01\/2018]. Available from: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/index.html<\/ext-link>."},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e0125018","DOI":"10.1371\/journal.pone.0125018","article-title":"Projected Lifetime Healthcare Costs Associated with HIV Infection","volume":"10","author":"F Nakagawa","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.arbres.2016.05.002","article-title":"Tuberculosis Costs in Spain and Related Factors","volume":"52","author":"JA Gullon","year":"2016","journal-title":"Arch Bronconeumol"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40258-016-0243-4","article-title":"Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain","volume":"14","author":"E Sabater","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"e105471","DOI":"10.1371\/journal.pone.0105471","article-title":"Cost of disorders of the brain in Spain","volume":"9","author":"O Pares-Badell","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e009148","DOI":"10.1136\/bmjopen-2015-009148","article-title":"Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network","volume":"5","author":"A Regueiro","year":"2015","journal-title":"BMJ Open"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12913-015-0725-3","article-title":"Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain)","volume":"15","author":"J Corral","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0b013e32834cdb4b","article-title":"Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata","volume":"25","author":"J Reekie","year":"2011","journal-title":"AIDS"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3851\/IMP2407","article-title":"The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression","volume":"17","author":"A Mocroft","year":"2012","journal-title":"Antivir Ther"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0272989X0202200103","article-title":"Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV\/AIDS","volume":"22","author":"BR Schackman","year":"2002","journal-title":"Medical decision making: an international journal of the Society for Medical Decision Making"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11136-005-8485-x","article-title":"The effect of diagnosis with HIV infection on health-related quality of Life","volume":"15","author":"S Honiden","year":"2006","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"e1000239","DOI":"10.1371\/journal.pmed.1000239","article-title":"Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy\u2014the CASCADE collaboration: a collaboration of 23 cohort studies","volume":"7","author":"M Wolbers","year":"2010","journal-title":"PLoS medicine"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/315339","article-title":"Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study","volume":"181","author":"RH Lyles","year":"2000","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0891-5520(05)70135-5","article-title":"Natural history of HIV-1 infection","volume":"14","author":"EN Vergis","year":"2000","journal-title":"Infectious disease clinics of North America"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda","volume":"191","author":"MJ Wawer","year":"2005","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/OLQ.0000000000000046","article-title":"Replacing clinic-based tests with home-use tests may increase HIV prevalence among Seattle men who have sex with men: evidence from a mathematical model","volume":"41","author":"DA Katz","year":"2014","journal-title":"Sexually transmitted diseases"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/590501","article-title":"HIV-1 transmission, by stage of infection","volume":"198","author":"TD Hollingsworth","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1258\/ijsa.2008.008268","article-title":"Time taken to undetectable viral load, following the initiation of HAART","volume":"20","author":"S Currie","year":"2009","journal-title":"International journal of STD & AIDS"},{"issue":"9210","key":"ref44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(00)02069-9","article-title":"Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe","volume":"355","author":"CASCADE Collaboration","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7326\/0003-4819-153-12-201012210-00004","article-title":"The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States","volume":"153","author":"EF Long","year":"2010","journal-title":"Annals of internal medicine"},{"issue":"9731","key":"ref46","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":"Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis","volume":"375","author":"D Donnell","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"e12598","DOI":"10.1371\/journal.pone.0012598","article-title":"Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk","volume":"5","author":"JR Lingappa","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"EL Murphy","year":"2001","journal-title":"Annals of internal medicine"},{"key":"ref50","unstructured":"(IMF) IMF. World Economic and Financial Surveys: Report for Selected Countries and Subjects 2017 [02\/01\/2018]. Available from: https:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2017\/02\/weodata\/weorept.aspx?sy=2005&ey=2017&scsm=1&ssd=1&sort=country&ds=.&br=1&pr1.x=23&pr1.y=12&c=184&s=NGDP%2CPCPI&grp=0&a#notes<\/ext-link>."},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/heapol\/16.3.326","article-title":"Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis","volume":"16","author":"JA Fox-Rushby","year":"2001","journal-title":"Health Policy Plan"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1472-6963-14-287","article-title":"Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences","volume":"14","author":"J Martin-Fernandez","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"ref53","first-page":"334","article-title":"[What is an efficient health technology in Spain?]","volume":"16","author":"JA Sacristan","year":"2002","journal-title":"Gac Sanit"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jval.2010.10.039","article-title":"The use of quality-adjusted life-years in the economic evaluation of health technologies in Spain: a review of the 1990\u20132009 literature","volume":"14","author":"JM Rodriguez","year":"2011","journal-title":"Value Health"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/cid\/cix212","article-title":"The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges","volume":"64","author":"A Gourlay","year":"2017","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/09540121.2015.1109584","article-title":"The continuum of HIV care in Catalonia","volume":"27","author":"CN Campbell","year":"2015","journal-title":"AIDS Care"},{"issue":"9","key":"ref57","first-page":"645","article-title":"[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]","volume":"29","author":"P Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"3","key":"ref58","first-page":"170","article-title":"[Linkage to care among new human immunodeficiency virus diagnoses in Spain]","volume":"32","author":"J Oliva","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/sextrans-2012-050481","article-title":"Prevalence of undiagnosed HIV infection in the general population having blood tests within primary care in Madrid, Spain","volume":"88","author":"S Moreno","year":"2012","journal-title":"Sex Transm Infect"},{"key":"ref60","unstructured":"Control ECfDPa. The status of the HIV response in the European Union\/European Economic Area, 2016. 2017."},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"E Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"ref62","unstructured":"IGUALDAD MDSSSE. Plan Estrat\u00e9gico de Prevenci\u00f3n y Control de la infecci\u00f3n por el VIH y otras infeccionesde transmisi\u00f3n sexual 2013\u20132016 2017 [06\/01\/2017]. Available from: http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/PlanEstrategico2013_2016.pdf<\/ext-link>."},{"key":"ref63","unstructured":"UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic 2014 [11\/01\/2017]. Available from: http:\/\/www.unaids.org\/en\/resources\/documents\/2017\/90-90-90<\/ext-link>."},{"key":"ref64","unstructured":"Del Amo J, editor Where are we in Spain? Gesida Congress 2016."},{"issue":"6","key":"ref65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eimc.2015.07.012","article-title":"Costs and cost-effectiveness analysis of 2015 GESIDA\/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults","volume":"34","author":"J Berenguer","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"e13132","DOI":"10.1371\/journal.pone.0013132","article-title":"Routine HIV screening in France: clinical impact and cost-effectiveness","volume":"5","author":"Y Yazdanpanah","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"e84173","DOI":"10.1371\/journal.pone.0084173","article-title":"Routine HIV screening in Portugal: clinical impact and cost-effectiveness","volume":"8","author":"Y Yazdanpanah","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eimc.2016.11.016","article-title":"Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016","volume":"35","author":"S Moreno","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:09:54Z","timestamp":1589008194000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206755"}},"subtitle":[],"editor":[{"given":"Giuseppe Vittorio","family":"De Socio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":68,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]}}}